Mutations in the TERT promoter have been detected in 3–7% of pediatric GBM [44,123] and tumor cells in this group maintain or increase telomere length through alternative lengthening of telomeres (ALT) pathway [127,128]. This evidence concerns the gene GPT and glioblastoma.